New drug restores breathing after spinal cord injury

Patients with high-level spinal cord injuries may face the inability to control their breathing. These patients often require artificial ventilation for the rest of their lives. Researchers have recently tested a substance called Hydrogel. The Hydrogel can deliver a neuron-protecting…

Experimental drug restores some bladder function after spinal cord injury

Researchers from Ohio State University have tested a drug that is showing promising results to improve bladder function after a spinal cord injury. After a month-long treatment after spinal cord injury in mice, bladder volume decreased significantly to a level…

Stem cell trial to repair injuried spinal cord produces encouraging results

Researchers at University of California San Diego School of Medicine report that a first-in-human phase I clinical trial in which neural stem cells were transplanted into participants with chronic spinal cord injuries produced measurable improvement in three of four subjects,…

Edging toward a breakthrough-Insurance Adviser May 2018

Between 350 and 400 new cases of spinal cord injury are recorded in Australia each year, costing the economy more than $2 billion– inclusive of ongoing care and rehabilitation. Thanks to the pioneering work of Prof Reggie Edgerton, however, those figures…

Patients with severe paralysis regain use of hands

Non-invasive surgical techniques aimed at stimulating the injured spinal cord are showing astounding results. The technique pioneered by Professor Reggie Edgerton is for the first time enabling people with severe paralysis to regain use of their hands. In the UCLA Edgerton…

Soft neural interfaces enable delivery of electrical and chemical stimulation to the spinal cord

New developments in soft neural interfaces are enabling the delivery of electrical and chemical stimulation to the spinal cord. The stimulations restored locomotion in animal models of paralysis. The soft interfaces can be placed either below or above the dura…

Phase 1/2a stem cell trial for acute spinal cord injury begins

Asterias Biotherapeutics has initiated patient enrolment for its Phase 1/2a clinical trial of AST-OPC1 stem cells for treating newly injured people with complete cervical spinal cord injury. “The Phase 1 study generated a strong package of data regarding the safety of AST-OPC1,” said…

Clinical trial testing autologous human Schwann cell transplantation for chronic SCI is open for enrollment:

Miami Project to Cure Paralysis: This trial is an FDA-approved Phase I clinical trial designed to test the safety of autologous human Schwann cells in participants with chronic spinal cord injury receiving rehabilitation.A total of 10 participants will be enrolled in…

Miami Project Schwann Trial for Chronic SCI Begins Enrollment for 10 people

This new trial will be primarily focused on safety, but in addition it will involve a preliminary evaluation of the efficacy of combining Schwann cells with exercise and rehabilitation. They only have FDA approval to transplant a maximum of 10 people…